Drug:
Reaction: DRUG INTERACTION
20250101 - 20251231
No. 701 - 800
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
701 | 25006506 |
GB |
91 | 2 |
Drug interaction, |
||||
LOSARTAN POTASSIUM, LOSARTAN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, NITROGLYCERIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LIRAGLUTIDE, CYANOCOBALAMIN, ALBUTEROL SULFATE, ALBUTEROL, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, AMITRIPTYLINE HYDROCHLORIDE, APIXABAN, BISOPROLOL FUMARATE, LANSOPRAZOLE, DAPAGLIFLOZIN, FUROSEMIDE, EPLERENONE, |
||||
702 | 25008766 |
65 | 2 | |
Drug interaction, COVID-19, |
||||
AVACOPAN, |
||||
703 | 25001429 |
US |
74 | 2 |
Muscle spasms, Dysstasia, Peripheral swelling, Muscle spasms, Abdominal pain, Gait disturbance, Drug interaction, Weight increased, Pain, Movement disorder, Blood pressure increased, Diarrhoea, Product storage error, Off label use, Muscle tightness, Arthralgia, Mass, Herpes zoster, |
||||
PANCRELIPASE, TOPIRAMATE, TOPIRAMATE SPINKLE, ERGOCALCIFEROL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FOLIC ACID, HYDROCHLOROTHIAZIDE, BENZONATATE, LANSOPRAZOLE, MONTELUKAST, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, PROPRANOLOL HYDROCHLORIDE, RABEPRAZOLE, CLARITHROMYCIN, PROPAFENONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
704 | 25005109 |
49 | 2 | |
Drug ineffective, Hyperhidrosis, Anxiety, Vertigo, Blood pressure increased, Heart rate increased, Body temperature increased, Confusional state, Insomnia, Limb discomfort, Brain fog, Muscle twitching, Drug interaction, Serotonin syndrome, |
||||
FEZOLINETANT, FEZOLINETANT, PROPRANOLOL HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, CLONAZEPAM, |
||||
705 | 24997657 |
ES |
85 | 1 |
Iron deficiency anaemia, Drug interaction, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ENALAPRIL, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, TAMSULOSIN HYDROCHLORIDE, TORSEMIDE, MIRABEGRON, |
||||
706 | 24998286 |
US |
52 | 2 |
Drug dependence, Drug interaction, Sleep-related eating disorder, Abnormal sleep-related event, Sleep sex, Fatigue, Somnolence, Somnambulism, Somnambulism, Drug ineffective, |
||||
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, MELATONIN, |
||||
707 | 24998525 |
US |
2 | |
Drug interaction, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
708 | 24999099 |
PL |
||
Vomiting, Abdominal pain upper, Serotonin syndrome, Nausea, Diarrhoea, Oedema peripheral, Seizure, Sedation, Altered state of consciousness, Delirium, Confusional state, Parasomnia, Convulsive threshold lowered, Hyperhidrosis, Respiratory depression, Drug intolerance, Drug interaction, Therapeutic product effect decreased, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, ALPRAZOLAM, BUPRENORPHINE, CLARITHROMYCIN, CELECOXIB, CHLORPROMAZINE, CLORAZEPATE DIPOTASSIUM, DULOXETINE HYDROCHLORIDE, DULOXETINE, FLUCONAZOLE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, METHADONE, METOPROLOL TARTRATE, METOPROLOL, METOCLOPRAMIDE HYDROCHLORIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MIRTAZAPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, PROMETHAZINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, |
||||
709 | 24999369 |
US |
49 | 1 |
Drug interaction, |
||||
CARBAMAZEPINE, TICAGRELOR, |
||||
710 | 24992713 |
US |
27 | 2 |
Toxicity to various agents, Immunosuppressant drug level increased, Exposure during pregnancy, Drug interaction, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITONAVIR, RITONAVIR 100 MG, AZATHIOPRINE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, |
||||
711 | 24992719 |
DE |
68 | |
Drug interaction, Sinusitis, Tinnitus, Nausea, |
||||
ESOMEPRAZOLE MAGNESIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FINASTERIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, TRIMIPRAMINE MALEATE, |
||||
712 | 24993096 |
US |
1 | |
Drug interaction, Product use in unapproved indication, |
||||
RIFAMPIN, ETHAMBUTOL HYDROCHLORIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
713 | 24993269 |
US |
14 | 1 |
Substance-induced psychotic disorder, Homicide, Drug interaction, Compulsive sexual behaviour, Serotonin syndrome, Completed suicide, Toxicity to various agents, Drug abuse, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, DEXTROMETHORPHAN, |
||||
714 | 24993337 |
SA |
||
Renal haemorrhage, Drug interaction, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, WARFARIN, HYDROXYCHLOROQUINE, AMLODIPINE, |
||||
715 | 24993682 |
CA |
54 | 1 |
Depression, Drug interaction, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, LAMIVUDINE, LAMIVUDINE ORAL, ATAZANAVIR SULFATE, ATAZANAVIR, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, CLONAZEPAM, SERTRALINE HYDROCHLORIDE, |
||||
716 | 24993816 |
US |
27 | 2 |
Drug interaction, Renal impairment, Condition aggravated, Hypertension, Toxicity to various agents, Exposure during pregnancy, Normal newborn, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, RITONAVIR, RITONAVIR 100 MG, AZATHIOPRINE, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, LAMIVUDINE, LAMIVUDINE ORAL, ABACAVIR SULFATE, ABACAVIR, RIFAMPIN, NICARDIPINE, LABETALOL, MAGNESIUM, FENTANYL, |
||||
717 | 24994001 |
FR |
72 | 1 |
Drug interaction, Immunosuppressant drug level increased, Thrombotic microangiopathy, COVID-19 pneumonia, Product use in unapproved indication, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NIRMATRELVIR AND RITONAVIR, REMDESIVIR, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
718 | 24994008 |
US |
27 | 2 |
Drug interaction, Toxicity to various agents, Immunosuppressant drug level increased, Exposure during pregnancy, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITONAVIR, RITONAVIR 100 MG, AZATHIOPRINE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, |
||||
719 | 24994118 |
CN |
34 | 2 |
SJS-TEN overlap, Drug interaction, |
||||
PACLITAXEL, CARBAMAZEPINE, |
||||
720 | 24994262 |
ES |
76 | 1 |
Rhabdomyolysis, Drug interaction, |
||||
ABIRATERONE ACETATE, ABIRATERONE, ROSUVASTATIN, |
||||
721 | 24994301 |
CA |
54 | 1 |
Depression suicidal, Drug interaction, Depression, Tearfulness, Psychomotor skills impaired, Psychotic disorder, Anxiety, Paranoia, Suicidal ideation, Depressive symptom, Loss of personal independence in daily activities, Psychiatric decompensation, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, SERTRALINE, VALPROIC ACID, TENOFOVIR DISOPROXIL FUMARATE, CLONAZEPAM, LOPINAVIR AND RITONAVIR, ATAZANAVIR, RISPERIDONE, LAMIVUDINE, LAMIVUDINE ORAL, RALTEGRAVIR, ENFUVIRTIDE, RITONAVIR, RITONAVIR 100 MG, EMTRICITABINE, BUPROPION HYDROCHLORIDE, BUPROPION, |
||||
722 | 24994325 |
ID |
1 | |
Conjunctival haemorrhage, International normalised ratio increased, Drug interaction, Ecchymosis, |
||||
PHENYTOIN SODIUM, VALPROIC ACID, WARFARIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), BISOPROLOL FUMARATE, ISOSORBIDE DINITRATE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, WARFARIN, |
||||
723 | 24994328 |
IN |
2 | |
Stupor, Toxicity to various agents, Balance disorder, Psychotic disorder, Nystagmus, Hyperreflexia, Drug interaction, |
||||
PHENYTOIN SODIUM, ISONIAZID, RIFAMPIN, PYRAZINAMIDE TABLET, PYRAZINAMIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
724 | 24994596 |
US |
27 | 2 |
Drug interaction, Toxicity to various agents, Maternal exposure during pregnancy, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, RITONAVIR, RITONAVIR 100 MG, AZATHIOPRINE, |
||||
725 | 24994795 |
US |
69 | 1 |
Therapeutic response shortened, Drug interaction, |
||||
PHENYTOIN, TICAGRELOR, |
||||
726 | 24994989 |
FR |
64 | 2 |
Retinal artery occlusion, Drug interaction, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TOPIRAMATE, TOPIRAMATE SPINKLE, BUSPIRONE HYDROCHLORIDE, |
||||
727 | 24995042 |
AU |
68 | 2 |
Drug interaction, Toxicity to various agents, Acute kidney injury, Confusional state, Headache, Tremor, Intentional product misuse, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, NIRMATRELVIR AND RITONAVIR, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
728 | 24995273 |
ES |
67 | 2 |
Hip fracture, Drug interaction, |
||||
LORAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, MIRTAZAPINE, |
||||
729 | 24995808 |
IT |
28 | 1 |
Somnolence, Brain fog, Disorientation, Drug interaction, |
||||
VALPROIC ACID, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, CARBAMAZEPINE, CLOBAZAM, CLOBAZAM, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, FELBAMATE, CLONAZEPAM, RUFINAMIDE, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, ETHOSUXIMIDE, ZONISAMIDE, PERAMPANEL, |
||||
730 | 24995923 |
PL |
||
Therapeutic product effect decreased, Vomiting, Abdominal pain upper, Serotonin syndrome, Nausea, Diarrhoea, Oedema peripheral, Drug interaction, Drug intolerance, Seizure, Sedation, Altered state of consciousness, Delirium, Confusional state, Parasomnia, Convulsive threshold lowered, Hyperhidrosis, Respiratory depression, |
||||
MIRTAZAPINE, METHADONE HYDROCHLORIDE, METHADONE, CLARITHROMYCIN, FLUCONAZOLE, PROMETHAZINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PALONOSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CHLORPROMAZINE, CELECOXIB, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, BUPRENORPHINE, METOPROLOL TARTRATE, METOPROLOL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ALPRAZOLAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, CLORAZEPATE DIPOTASSIUM, ZOLPIDEM TARTRATE, TRAMADOL HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
731 | 24996249 |
FR |
74 | 1 |
Lactic acidosis, Drug interaction, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, IOVERSOL, |
||||
732 | 24996482 |
US |
75 | 1 |
Drug interaction, Adverse event, Drug screen positive, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE, |
||||
733 | 24996730 |
FR |
55 | 2 |
Drug interaction, Bone tuberculosis, Condition aggravated, |
||||
ADALIMUMAB, METHOTREXATE SODIUM, PREDNISONE, |
||||
734 | 24996796 |
CH |
30 | 1 |
Miosis, Hypothermia, Depressed level of consciousness, Accidental overdose, Drug interaction, |
||||
735 | 24988028 |
FR |
72 | 1 |
Hypertensive crisis, Thrombotic microangiopathy, Hypertensive crisis, Neurotoxicity, COVID-19 pneumonia, Renal impairment, Haematocrit decreased, Microangiopathy, Immunosuppressant drug level increased, Red blood cell count decreased, Haematotoxicity, Drug interaction, Overdose, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, NIRMATRELVIR AND RITONAVIR, REMDESIVIR, |
||||
736 | 24988035 |
US |
27 | 2 |
Toxicity to various agents, Drug interaction, Immunosuppressant drug level increased, Renal impairment, Hypertension, Condition aggravated, Exposure during pregnancy, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AZATHIOPRINE, ABACAVIR SULFATE, ABACAVIR, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, FENTANYL, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, LABETALOL, LAMIVUDINE, LAMIVUDINE ORAL, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, NICARDIPINE, NICARDIPINE, RIFAMPIN, RIFAMPIN, RITONAVIR, RITONAVIR 100 MG, |
||||
737 | 24988072 |
GB |
2 | |
Mobility decreased, Asthenia, Drug interaction, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
738 | 24988114 |
US |
2 | |
Drug interaction, Device leakage, Adverse drug reaction, Device breakage, Stoma site reaction, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PANTOPRAZOLE, BACLOFEN, LEVOTHYROXINE, DOFETILIDE, FOLIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, ZINC OXIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LINACLOTIDE, PRAMIPEXOLE DIHYDROCHLORIDE, AMANTADINE, AMANTADINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PREDNISONE, ESZOPICLONE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
739 | 24988759 |
US |
27 | 2 |
Renal impairment, Condition aggravated, Toxicity to various agents, Hypertension, Drug interaction, Maternal exposure during pregnancy, |
||||
DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, RITONAVIR, RITONAVIR 100 MG, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, AZATHIOPRINE, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, FENTANYL, NICARDIPINE, LABETALOL, MAGNESIUM, |
||||
740 | 24988960 |
CA |
11 | 2 |
Mucocutaneous ulceration, Condition aggravated, Drug interaction, Drug ineffective for unapproved indication, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
741 | 24988969 |
GB |
2 | |
Dysarthria, Drug interaction, Malaise, Nausea, Balance disorder, Vision blurred, Toxicity to various agents, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, CARBAMAZEPINE, |
||||
742 | 24989317 |
CA |
2 | |
Chest pain, Abdominal pain, Dizziness, Drug interaction, Dyspnoea, Gait inability, Headache, Hypertension, Myalgia, Pain, Pyrexia, Rash, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
743 | 24989616 |
FR |
68 | 1 |
Drug-induced liver injury, Taste disorder, Drug level increased, Fatigue, Overdose, Dyspnoea, Drug interaction, Decreased appetite, Nephropathy toxic, Asthenia, Toxicity to various agents, Drug intolerance, |
||||
VORICONAZOLE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
744 | 24989689 |
US |
2 | |
Drug interaction, |
||||
IBRUTINIB, LEVOTHYROXINE, LEVOTHYROXINE, IBRUTINIB, |
||||
745 | 24990080 |
FR |
64 | 2 |
Retinal artery occlusion, Drug interaction, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
746 | 24990403 |
BE |
56 | 2 |
Liver function test increased, Hepatitis, Drug interaction, Product use issue, Off label use, |
||||
AZITHROMYCIN DIHYDRATE, IVACAFTOR, AMIKACIN, ALBUTEROL SULFATE, SACCHAROMYCES CEREVISIAE, |
||||
747 | 24990577 |
PT |
32 | 2 |
Drug interaction, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, TUCATINIB, |
||||
748 | 24990642 |
US |
1 | |
Drug interaction, |
||||
RIFAMPIN, RIFABUTIN, |
||||
749 | 24990686 |
AU |
2 | |
Acute kidney injury, Major depression, Serotonin syndrome, Suicide attempt, Metabolic acidosis, Physical deconditioning, Drug interaction, Intentional overdose, |
||||
FLUOXETINE HYDROCHLORIDE, AMLODIPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOFACITINIB, VALSARTAN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, SEROTONIN (HYDROCHLORIDE), SEROTONIN, |
||||
750 | 24990783 |
US |
72 | 1 |
Therapeutic product effect decreased, Drug interaction, |
||||
PHENYTOIN, PHENYTOIN, TICAGRELOR, PHENOBARBITAL, PHENOBARBITAL, |
||||
751 | 24991026 |
JP |
50 | 1 |
Immunosuppressant drug level increased, Renal disorder, COVID-19, Drug interaction, |
||||
TACROLIMUS, NIRMATRELVIR AND RITONAVIR, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
752 | 24991638 |
US |
||
Renal impairment, Hypertension, Drug interaction, Condition aggravated, Toxicity to various agents, Exposure during pregnancy, |
||||
NICARDIPINE HYDROCHLORIDE, NICARDIPINE, NICARDIPINE HYDROCHLORIDE, NICARDIPINE, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, RITONAVIR, RITONAVIR 100 MG, LAMIVUDINE, LAMIVUDINE ORAL, ABACAVIR SULFATE, ABACAVIR, ZIDOVUDINE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AZATHIOPRINE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, RIFAMPIN, FENTANYL, LABETALOL, LABETALOL, |
||||
753 | 24991676 |
CH |
73 | 2 |
Pulmonary hypertension, Cardiomegaly, Cough, Dyspnoea exertional, Weight decreased, Campylobacter gastroenteritis, Drug interaction, Pancytopenia, Cardiac failure congestive, |
||||
LEFLUNOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, CANDESARTAN, PANTOPRAZOLE, ROSUVASTATIN, |
||||
754 | 24991719 |
PT |
76 | 1 |
Serotonin syndrome, Rhabdomyolysis, Drug interaction, Drug ineffective, |
||||
RASAGILINE MESYLATE, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LISINOPRIL, AMLODIPINE, |
||||
755 | 24991776 |
TW |
55 | 2 |
Atrioventricular block complete, Drug interaction, |
||||
ESTAZOLAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, VALPROATE SODIUM, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, TELMISARTAN, |
||||
756 | 24991967 |
FR |
68 | 1 |
Drug interaction, Toxicity to various agents, |
||||
ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, |
||||
757 | 24991977 |
IT |
77 | 1 |
Cerebral haemorrhage, Drug interaction, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, CLOPIDOGREL, RIVAROXABAN, PANTOPRAZOLE, BISOPROLOL FUMARATE, |
||||
758 | 24991999 |
ES |
92 | 2 |
Chronic kidney disease, Condition aggravated, Inappropriate antidiuretic hormone secretion, Hyponatraemia, Drug interaction, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, FUROSEMIDE, SPIRONOLACTONE, |
||||
759 | 24992040 |
JP |
71 | 2 |
Pneumocystis jirovecii pneumonia, Cytomegalovirus test positive, Drug interaction, Blood potassium increased, |
||||
UPADACITINIB, LEMBOREXANT, MAGNESIUM OXIDE, AZILSARTAN KAMEDOXOMIL, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHOTREXATE, METHOTREXATE SODIUM, AMLODIPINE BESYLATE, LINAGLIPTIN, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TACROLIMUS, FOLIC ACID, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LULICONAZOLE, LULICONAZOLE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE TABLETS 250 MG, TERBINAFINE HYDROCHLORIDE 1G IN 100G, |
||||
760 | 24992199 |
US |
69 | 1 |
Therapeutic product effect decreased, Drug interaction, |
||||
PHENYTOIN, TENECTEPLASE, TICAGRELOR, |
||||
761 | 24992235 |
US |
49 | 1 |
Therapeutic product effect decreased, Drug interaction, |
||||
CARBAMAZEPINE, TICAGRELOR, |
||||
762 | 24983511 |
US |
57 | 1 |
Toxic epidermal necrolysis, Drug interaction, Product use in unapproved indication, |
||||
OXALIPLATIN, NIVOLUMAB, FLUOROURACIL, |
||||
763 | 24983632 |
BR |
90 | 2 |
Fall, Vomiting, Nausea, Abdominal pain, Pain, Drug interaction, |
||||
MIRABEGRON, MIRABEGRON, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, AMLODIPINE BESYLATE, |
||||
764 | 24983863 |
CA |
1 | |
Depression, Drug interaction, |
||||
ATAZANAVIR, CLONAZEPAM, LAMIVUDINE, LAMIVUDINE ORAL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, SERTRALINE, DIVALPROEX SODIUM, BUPROPION HYDROCHLORIDE, BUPROPION, EFAVIRENZ, LOPINAVIR AND RITONAVIR, |
||||
765 | 24983991 |
US |
27 | 2 |
Toxicity to various agents, HIV infection, Abdominal pain upper, Disease recurrence, Hypertension, Renal impairment, Maternal exposure during pregnancy, Drug interaction, Drug interaction, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, RITONAVIR, RITONAVIR 100 MG, RITONAVIR, RITONAVIR 100 MG, RIFAMPIN, AZATHIOPRINE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, |
||||
766 | 24983995 |
US |
65 | 2 |
Toxic epidermal necrolysis, Drug interaction, Product use in unapproved indication, |
||||
CARBOPLATIN, PEMBROLIZUMAB, PACLITAXEL, |
||||
767 | 24984056 |
CA |
||
Vasculitis, Vascular pain, Back pain, Disturbance in attention, Dizziness, Drug interaction, Fatigue, Headache, Immune-mediated adverse reaction, Irritability, Mental disorder, Neuralgia, Muscle twitching, Off label use, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, DALTEPARIN SODIUM, DALTEPARIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
768 | 24984193 |
JP |
48 | 1 |
Extrapyramidal disorder, Drug interaction, |
||||
VALPROIC ACID, RISPERIDONE, PALIPERIDONE, EMPAGLIFLOZIN, BREXPIPRAZOLE, PALIPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, |
||||
769 | 24984269 |
AU |
||
Accidental poisoning, Drug interaction, Off label use, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
770 | 24984407 |
DK |
1 | |
Drug level below therapeutic, Drug level increased, Drug interaction, |
||||
CLOBAZAM, CLOBAZAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, FOSPHENYTOIN, FOSPHENYTOIN SODIUM, FOSPHENYTOIN, FOSPHENYTOIN SODIUM, MEROPENEM, MEROPENEM, PHENOBARBITAL, PHENOBARBITAL, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, ANIDULAFUNGIN, ANIDULAFUNGIN, BACLOFEN, PENICILLIN G, CERLIPONASE ALFA, CLONAZEPAM, CLONIDINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FENTANYL, FLUCONAZOLE, GABAPENTIN, GENTAMICIN, GENTAMICIN SULFATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LORAZEPAM, MELATONIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MORPHINE, MORPHINE, NAPROXEN, NAPROXEN SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PROPOFOL, |
||||
771 | 24984531 |
US |
||
Flushing, Blood pressure decreased, Hot flush, Drug interaction, Hypoacusis, Tinnitus, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ALLOPURINOL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, EMPAGLIFLOZIN, GABAPENTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PREDNISONE, OXYGEN, 0XYGEN, |
||||
772 | 24984547 |
FR |
||
Retinal artery occlusion, Drug interaction, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, BUSPIRONE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
773 | 24984748 |
72 | 1 | |
Drug interaction, Overdose, Off label use, Hypertensive crisis, Neurotoxicity, Renal impairment, Red blood cell count decreased, Haematocrit decreased, Confusional state, Agitation, Thrombotic microangiopathy, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, REMDESIVIR, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
774 | 24984750 |
27 | 2 | |
Toxicity to various agents, Drug interaction, Maternal exposure during pregnancy, Off label use, Abdominal pain upper, Hypertension, Renal impairment, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BETAMETHASONE DIPROPIONATE, DARUNAVIR, DARUNAVIR 600 MG, DARUNAVIR 800 MG, RITONAVIR, RITONAVIR 100 MG, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, AZATHIOPRINE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, LAMIVUDINE, LAMIVUDINE ORAL, ABACAVIR SULFATE, ABACAVIR, |
||||
775 | 24984873 |
FR |
16 | 2 |
Toxicity to various agents, Confusional state, Hallucination, Sinus tachycardia, Drug interaction, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, SERTRALINE, |
||||
776 | 24985083 |
CN |
68 | 2 |
Renal haemorrhage, Drug interaction, Coagulopathy, Toxicity to various agents, Acute kidney injury, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, NIRMATRELVIR AND RITONAVIR, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, DOPAMINE HYDROCHLORIDE, DOPAMINE, DOPAMINE HYDROCHLORIDE, DOPAMINE, DOPAMINE HYDROCHLORIDE, DOPAMINE, |
||||
777 | 24985121 |
US |
||
Hospitalisation, Hypertension, Tremor, Nausea, Drug interaction, Drug ineffective, Insomnia, Palpitations, Headache, Hyperhidrosis, |
||||
DEUTETRABENAZINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
778 | 24985217 |
76 | 2 | |
Stomatitis, Pancytopenia, Product use in unapproved indication, Drug interaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, AMOXICILLIN, |
||||
779 | 24985314 |
US |
37 | 2 |
Off label use, Incorrect dose administered, Drug interaction, Headache, Energy increased, Fatigue, Eructation, Diarrhoea, Dehydration, Abdominal discomfort, Dyspepsia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
780 | 24985403 |
US |
52 | 2 |
Drug dependence, Somnolence, Fatigue, Drug interaction, Somnambulism, Somnambulism, Sleep-related eating disorder, Abnormal sleep-related event, Sleep sex, Drug ineffective, |
||||
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, MELATONIN, |
||||
781 | 24985469 |
US |
8 | 2 |
Treatment failure, Sepsis, Drug interaction, Off label use, |
||||
PREDNISONE, PREDNISONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE, OCTREOTIDE, RIFAMPIN, COLCHICINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
782 | 24985801 |
IN |
52 | 1 |
Choking, Burning sensation, Chills, Feeling abnormal, Palpitations, Flushing, Dyspnoea, Rash, Drug interaction, |
||||
OXALIPLATIN, |
||||
783 | 24985965 |
GB |
55 | 2 |
Psychotic disorder, Incoherent, Irritability, Memory impairment, Decreased appetite, Cachexia, Mood swings, Aggression, Anger, Renal pain, Back pain, Pallor, Drug interaction, Affective disorder, Depression, Drug dependence, |
||||
RAMIPRIL, NAPROXEN, NAPROXEN SODIUM, TIRZEPATIDE, |
||||
784 | 24986451 |
ES |
2 | |
Somnolence, Wrong product administered, Drug interaction, |
||||
MIRTAZAPINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, BRIVARACETAM, CLONAZEPAM, LORAZEPAM, |
||||
785 | 24986458 |
CH |
80 | 2 |
Drug interaction, Overdose, Irregular breathing, Miosis, Consciousness fluctuating, |
||||
DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, FENTANYL, FENTANYL, FENTANYL, |
||||
786 | 24986551 |
US |
14 | 1 |
Serotonin syndrome, Substance-induced psychotic disorder, Completed suicide, Drug interaction, Drug abuse, Toxicity to various agents, Compulsive sexual behaviour, Homicide, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, DEXTROMETHORPHAN, |
||||
787 | 24986726 |
ES |
90 | 2 |
Nausea, Constipation, Hallucination, auditory, Drug interaction, |
||||
FENTANYL, |
||||
788 | 24986856 |
US |
||
Alopecia, Depression, Stress, Onychoclasis, Drug interaction, Recalled product administered, Drug ineffective, Recalled product, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE, |
||||
789 | 24986991 |
TR |
11 | 2 |
Psychotic disorder, Drug interaction, |
||||
METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
790 | 24987059 |
FR |
72 | 1 |
Drug interaction, Overdose, Renal impairment, Hypertensive crisis, Microangiopathy, Thrombotic microangiopathy, Red blood cell count decreased, Haematocrit decreased, |
||||
NIRMATRELVIR AND RITONAVIR, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, REMDESIVIR, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
791 | 24987155 |
ES |
86 | 1 |
Drug interaction, Hyponatraemia, Condition aggravated, |
||||
SPIRONOLACTONE, FUROSEMIDE, |
||||
792 | 24987569 |
FR |
83 | 1 |
Angioedema, Drug interaction, |
||||
SITAGLIPTIN, PANTOPRAZOLE, ROSUVASTATIN, SPIRONOLACTONE, BISOPROLOL FUMARATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TAMSULOSIN HYDROCHLORIDE, |
||||
793 | 24978851 |
PL |
81 | 2 |
Seizure, Epilepsy, Drug interaction, Anticoagulation drug level decreased, Drug level below therapeutic, Potentiating drug interaction, |
||||
RIVAROXABAN, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, OXCARBAZEPINE, VALSARTAN, FUROSEMIDE, |
||||
794 | 24979164 |
FR |
||
Drug interaction, Angioedema, |
||||
SITAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, SPIRONOLACTONE, BISOPROLOL FUMARATE, PANTOPRAZOLE, |
||||
795 | 24979447 |
AU |
75 | 2 |
Chills, Pyrexia, Tachypnoea, Dyspnoea, Hypertension, Dizziness, Malaise, Drug interaction, Suspected transmission of an infectious agent via product, Product quality issue, Chills, Tachypnoea, Malaise, Dizziness, |
||||
796 | 24979480 |
CA |
54 | 1 |
Depression, Drug interaction, |
||||
CLONAZEPAM, LAMIVUDINE, LAMIVUDINE ORAL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ATAZANAVIR SULFATE, ATAZANAVIR, SERTRALINE HYDROCHLORIDE, |
||||
797 | 24979554 |
PT |
76 | 1 |
Serotonin syndrome, Rhabdomyolysis, Drug interaction, Drug ineffective, |
||||
DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, RASAGILINE, RASAGILINE MESYLATE, AMLODIPINE, LISINOPRIL, |
||||
798 | 24979656 |
US |
27 | 1 |
Drug-induced liver injury, Toxicity to various agents, Drug interaction, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
799 | 24979680 |
US |
72 | 1 |
Therapeutic response shortened, Drug interaction, |
||||
PHENYTOIN, PHENOBARBITAL, TICAGRELOR, |
||||
800 | 24979771 |
US |
15 | 1 |
Blindness, Blindness transient, Eye inflammation, Eye irritation, Eye pain, Papilloedema, Photophobia, Visual impairment, Drug interaction, Drug ineffective, Product dispensing error, |
||||
OLANZAPINE, CLONAZEPAM, BUPROPION HYDROCHLORIDE, CLONIDINE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28